Product description

Drug product for the treatment of infective diarrhea (adult and children), traveler's diarrhea and dysbiosis.  Based on proprietary probiotic strain SF68®, with unique characteristics and manufactured under pharmaceuticals GMPs.  Its efficacy is supported by more than 20 clinical trials and its safety is confirmed by a recent (2018) publication and by more than 100 million patients treated along 40 years of commercialization.
Registered as drug product in Switzerland (Bioflorin), Austria, Italy and Korea.

Available a full CTD dossier and a CPP (Certificate of Pharmaceutical Product) from Switzerland. 

Cerbios is looking for commercial Partners worldwide.
Read more

Specifications

Categories Probiotics
Sales markets Western Europe; Asia
Supplied from Switzerland
Product Applications Food Supplements; Pharmaceutical
Product Certifications Health & Safety (GMP, HAACP and equivalents)

Products from other suppliers

Newflora SF68®- (drug)

Contact information

Address

Email

Telephone

Website

View all contact information